Schedule of Warrant Activity (Details) - Warrant [Member] - USD ($) |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
|
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Warrants Outstanding, Beginning Balance | 71,250 | |
Weighted-Average Exercise Price, Beginning Balance | $ 6.25 | |
Weighted-Average Remaining Contractual Term, Outstanding | 4 years 9 months | 5 years |
Aggregate Intrinsic Value, Beginning Balance | ||
Warrants, Granted | ||
Weighted-Average Exercise Price, Granted | ||
Warrants, Exercised | ||
Weighted-Average Exercise Price, Exercised | ||
Warrants, Cancelled/Exchanged | ||
Weighted-Average Exercise Price, Cancelled/Exchanged | ||
Warrants Outstanding, Ending Balance | 71,250 | 71,250 |
Weighted-Average Exercise Price, Ending Balance | $ 6.25 | $ 6.25 |
Aggregate Intrinsic Value, Ending Balance | ||
Warrants, Exercisable | 71,250 | |
Weighted-Average Exercise Price, Exercisable | $ 6.25 | |
Weighted-Average Remaining Contractual Term, Exercisable | 4 years 9 months | |
Aggregate Intrinsic Value, Exercisable |
X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options equity instruments exercisable intrinsic value. No definition available.
|
X | ||||||||||
- Definition Non Option Equity Instruments Exercisable Number. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options equity instruments outstanding intrinsic value. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options equity instruments outstanding weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Non Options Exercisable Weighted Average Exercise Price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options equity instruments exercised weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options equity instruments forfeitures and expirations weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options equity instruments grants in period weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercisable weighted average remaining contractual term. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options equity instruments outstanding weighted average remaining contractual term. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|